Mining the genome for susceptibility to complex neurological disorders
1National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD, USA.
Current Molecular Medicine
|October 29, 2009
Summary
Genome-wide association studies (GWAS) are crucial for identifying genetic risk factors in complex neurological disorders. This review discusses major GWAS findings, their limitations, and implications for understanding disease etiology.
Area of Science:
- Genetics
- Neurology
- Genomic Epidemiology
Background:
- Genome-wide association studies (GWAS) are increasingly utilized to identify genomic regions associated with neurological disorder risk.
- Linkage studies are effective for Mendelian disorders but less suitable for complex common disorders.
- GWAS have become the primary method for investigating the genetic basis of complex neurological conditions.
Purpose of the Study:
- To review major genome-wide association studies (GWAS) conducted in neurological disorders.
- To discuss the limitations inherent in current GWAS methodologies.
- To explore the implications of existing GWAS findings for the field of neurology.
Main Methods:
- Review and synthesis of published genome-wide association studies (GWAS) in neurological disorders.
- Critical analysis of the methodologies and statistical approaches employed in these studies.
- Evaluation of the reported genetic loci and their potential functional relevance.
Main Results:
- Several major GWAS in neurological disorders have identified significant genetic loci.
- Limitations include issues with statistical power, population stratification, and effect size estimation.
- Findings highlight the polygenic nature of many neurological disorders.
Conclusions:
- GWAS are powerful tools for dissecting the genetic architecture of neurological disorders.
- Addressing current limitations is essential for advancing the field.
- Continued GWAS research holds significant implications for disease understanding and therapeutic development.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...